Allogene Therapeutics

Allogene Therapeutics(ALLO)

SOUTH SAN FRANCISCO, CA
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: CAR-T

Allogene Therapeutics is a life sciences company focused on CAR-T.

Cell Therapy
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
2

Pipeline & Clinical Trials

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
Hematologic Malignancies
N/A
Clinical Trials (1)
NCT06925685Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
N/A
Phase 1
Clinical Trials (1)
NCT07085104A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Phase 1
Phase 1
Clinical Trials (1)
NCT04093596Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
Phase 1
Phase 1
Clinical Trials (1)
NCT04696731Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 1
Phase 1
Clinical Trials (1)
NCT03939026Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
Phase 1
Phase 1/2
Clinical Trials (1)
NCT05000450Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT04416984Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
Phase 1/2
Phase 2
Clinical Trials (1)
NCT05714345Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
Phase 2
cemacabtagene ansegedleucel
Large B-cell Lymphoma
Phase 2
Clinical Trials (1)
NCT06500273Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 2

Open Jobs (2)

Director, Accounting

South San Francisco, CA, US
Finance
2w ago
$200K - $230K/yr

SAP Business Systems and Master Data Specialist (Contract)

South San Francisco, CA, US
Supply Chain
3w ago
Interview Prep Quick Facts
Portfolio: 9 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 2 active jobs

Financials (FY2025)

Revenue
$22K77%
R&D Spend
$192M(874086%)21%
Net Income
-$258M
Cash
$75M
Source: SEC 10-K Filing

Hiring Trend

Stable
2
Open Roles
+3
Added
-1
Filled/Removed

Based on last 3 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub